title: Long-term infusional systems: complications in cancer patients.
abstract: Long-term central vein catheters have found clinical application in different fields of medicine and particularly in oncology. In fact, the continuous infusion of some drugs has become the standard treatment in a wide variety of cancers, but central vein catheters are not without risks. The authors report their experience with central vein catheters. From January 1,1998, to December 31, 1999, 98 central vein catheters were placed in neoplastic patients. Seventy-seven (78.6%) Groshong and 16 (16.3%) Port-a-cath catheters were used. The central vein catheters were placed under local anesthesia. Before placement of the central vein catheters, the patients were checked by chest X-ray and neck ultrasonography. The procedure was performed under fluoroscopic control. The central vein catheters were flushed periodically with normal saline solution and sodium heparin. Sterile transparent adhesive dressings were used to occlude the operative site. The median follow-up of patients was 9 catheter months (range, 1-24 months). There were a few early and late clinically evident complications. The early complications were dislodgement in 5 cases (5.1%). The late complications were: fibrin sleeve in 1 case (1.1%), thrombosis in 2 cases (2.1%) and skin infection in 4 cases (4.1%). The low prevalence of major complications related to implants and management of these supports an increased use in oncology.
authors.affiliation: Department of Medical Oncology, Ospedale Oncologico Regionale, Centro di Riferimento Oncologico della Basilicata (CROB), Rionero In Vulture (PZ), Italy. Mcoccaro@hotmail.com
authors.forename: M
authors.initials: M
authors.lastname: Coccaro
authors.forename: A M
authors.initials: AM
authors.lastname: Bochicchio
authors.forename: A M
authors.initials: AM
authors.lastname: Capobianco
authors.forename: P
authors.initials: P
authors.lastname: Di Leo
authors.forename: G
authors.initials: G
authors.lastname: Mancino
authors.forename: A
authors.initials: A
authors.lastname: Cammarota
mesh_terms: D000328:Adult; D000368:Aged; D002405:Catheterization, Central Venous / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*